Quantum BioPharma Ltd.
(NASDAQ) QNTM
Quantum BioPharma Ltd. Financials at a Glance
Market Cap
$25.15M
Revenue (TTM)
$0.00
Net Income (TTM)
-$30.97M
EPS (TTM)
-$8.26
P/E Ratio
-0.48
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$4.00
Volume
194,885
Open
$3.86
Price
$4.00
Volume
194,885
Open
$3.86
Previous Close
$4.00
Daily Range
$3.71 - $4.13
52-Week Range
$2.07 - $38.25
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$4.00
Volume
194,885
Open
$3.86
Previous Close
$4.00
Daily Range
$3.71 - $4.13
52-Week Range
$2.07 - $38.25
Estimated Earnings Date
Aug 6, 2026
QNTM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Quantum BioPharma Ltd.
Industry
Pharmaceuticals
Sector
Health CareEmployees
7
CEO
Zeeshan Saeed
Website
www.quantumbiopharma.comHeadquarters
Toronto, ON M5J 2H7, CA
QNTM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-985%
Return on Capital
3%
Return on Assets
-2%
Earnings Yield
-2.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$25.15M
Shares Outstanding
6.40M
Volume
194.88K
Avg. Volume
556.19K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$15.30M
EBITDA
-$25.79M
Operating Cash Flow
-$8.38M
Capital Expenditure
$0.00
Free Cash Flow
-$8.38M
Cash & ST Invst.
$6.17M
Total Debt
$1.87M
Quantum BioPharma Ltd. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$125.67K
N/A
Gross Margin
0.00%
N/A
Market Cap
$25.15M
N/A
Market Cap/Employee
$1.48M
N/A
Employees
17
N/A
Net Income
-$13.37M
-55.9%
EBITDA
-$2.74M
+66.8%
Quarterly Fundamentals
Total Cash
$10.07M
+184.4%
Total Debt
$872.92K
-31.8%
Accounts Receivable
$209.21K
-93.9%
Inventory
$51.64K
-45.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$872.92K
-31.8%
Return on Assets
-2.07%
N/A
Return on Invested Capital
3.17%
N/A
Free Cash Flow
-$1.65M
+61.4%
Operating Cash Flow
-$1.65M
+61.4%